Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

Patients
  • Our Medicines
  • Financial Support
  • Genentech Patient Foundation
  • Understanding Insurance
  • Medicine Information Support
  • Clinical Trial Information
  • Advancing Inclusive Research
  • Our Approach to Pricing
  • Patient Advocacy
  • Create With Us
  • Disease Education
Patients / Our Medicines

Our Medicines & Products

  • Medicines
  • Actemra®
    (TOCILIZUMAB [authorized for Emergency Use])
  • Actemra®
    (tocilizumab)
    Actemra
  • Activase®
    (alteplase)
    Activase
  • Alecensa®
    (alectinib)
    Alecensa
  • Avastin®
    (bevacizumab)
    Avastin
  • Boniva Tablets®
    (ibandronate sodium)
    Boniva Tablets
  • Cathflo Activase®
    (alteplase)
    Cathflo Activase
  • CellCept®
    (mycophenolate mofetil)
    CellCept
  • Cotellic®
    (cobimetinib)
    Cotellic
  • Enspryng®
    (satralizumab-mwge)
    Enspryng
  • Erivedge®
    (vismodegib)
    Erivedge
  • Esbriet®
    (pirfenidone)
    Esbriet
  • Evrysdi®
    (risdiplam)
    Evrysdi
  • Floodlight™
    (MS)
    Floodlight
  • Fuzeon®
    (enfuvirtide)
    Fuzeon
  • Gavreto®
    (pralsetinib)
    Gavreto
  • Gazyva®
    (obinutuzumab)
    Gazyva
  • Hemlibra®
    (emicizumab-kxwh)
    Hemlibra
  • Herceptin®
    (trastuzumab)
    Herceptin
  • Herceptin Hylecta™
    (trastuzumab and hyaluronidase-oysk)
    Herceptin Hylecta
  • Invirase®
    (saquinavir mesylate)
  • Kadcyla®
    (ado-trastuzumab emtansine)
    Kadcyla
  • Lucentis®
    (ranibizumab injection)
    Lucentis
  • Lunsumio™
    (mosunetuzumab-axgb)
    Lunsumio
  • Nutropin AQ®
    ((somatropin) injection for subcutaneous use)
    Nutropin AQ
  • Ocrevus®
    (ocrelizumab)
    Ocrevus
  • Perjeta®
    (pertuzumab)
    Perjeta
  • Phesgo®
    (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
    Phesgo
  • Polivy®
    (polatuzumab vedotin-piiq)
    Polivy
  • Pulmozyme®
    (dornase alfa)
    Pulmozyme
  • Rituxan®
    (rituximab [Immunology])
    Rituxan
  • Rituxan®
    (rituximab [Oncology])
    Rituxan
  • Rituxan Hycela®
    (rituximab and hyaluronidase human)
    Rituxan Hycela
  • Rozlytrek®
    (entrectinib)
    Rozlytrek
  • Susvimo™
    (ranibizumab injection)
    Susvimo
  • Tamiflu®
    (oseltamivir phosphate)
    Tamiflu
  • Tarceva®
    (erlotinib)
    Tarceva
  • Tecentriq®
    (atezolizumab)
    Tecentriq
  • TNKase®
    (tenecteplase)
    TNKase
  • Vabysmo®
    (faricimab-svoa)
    Vabysmo
  • Valcyte®
    (valganciclovir hydrochloride)
    Valcyte
  • Venclexta®
    (venetoclax)
    Venclexta
  • Xeloda®
    (capecitabine)
    Xeloda
  • Xofluza®
    (baloxavir marboxil)
    Xofluza
  • Xolair®
    (omalizumab)
    Xolair
  • Zelboraf®
    (vemurafenib)
    Zelboraf

You Might Also Be Interested In

  • Patient Resource Center

    Our patient resource center is dedicated to getting patients and caregivers to the right resources.

    1 (877) GENENTECH (436-3683)
    Monday-Friday, 6am-5pm PST

  • Report a side effect

    You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.

    You may also report side effects to Genentech at (888) 835-2555.

  • Medicine Information Support
    Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine.

    Call a nurse

    By calling (800) 821-8590
    Monday-Friday, 5am-5pm PT.

    Chat with a nurse

    Use our online chat feature
    Monday-Friday, 5am-5pm PT.

    Email a nurse

    By filling out this form.

  • Sharps Disposal

    A guide for dealing with used sharps responsibly.

  • Access to Investigational Medicines

    We're committed to a fair and impartial evaluation of each request for access to our investigational medicines.

  • Find Open Clinical Trials

    Search clinicaltrials.gov to find out if a trial exists for a specific medicine for a particular disease.

Access to Medicines

Genentech Access Solutions offers coverage support, patient assistance, other useful information.

  • Now Hiring
  • Find A Job
  • Professional Areas
  • Diversity & Inclusion
  • Chief Diversity Officer
  • Fostering Belonging
  • Health Equity
  • Advancing Inclusive Research
  • Transforming Society
  • Our 2021 Diversity & Inclusion Report
  • Our Work in Action
  • Kindergarten to Careers
  • For Scientists
  • Our Scientists
  • Publications
  • Oncology
  • Immunology
  • Neuroscience
  • Metabolism
  • Infectious Disease
  • Ophthalmology
  • For Patients
  • Our Medicines
  • Financial Support
  • Genentech Patient Foundation
  • Understanding Insurance
  • Medicine Information Support
  • Clinical Trial Information
  • Advancing Inclusive Research
  • Our Approach to Pricing
  • Patient Advocacy
  • Create With Us
  • Disease Education
  • For Medical Professionals
  • Our Medicines & Products
  • Our Pipeline
  • Medical Resources
  • Clinical Trial Information
  • Sunshine Act Compliance
  • Product Security
  • For Partners
  • Our Approach
  • What We Are Looking For
  • Partner With Us
  • Our Stories
  • For Media
  • News Features
  • Press Releases
  • Statements
  • Company Information
  • Sign Up For News Alerts
  • For Good
  • Giving
  • Diversity & Inclusion
  • Sustainability
  • About Us
  • Leadership
  • Policy & Advocacy
  • Our Focus on Oncology
  • Awards & Recognition
  • Investors
  • Suppliers
  • Our Approach to Pricing
  • CA Transparency in Supply
  • Compliance Overview
  • Contact Us
  • Call Us
  • Email Us
  • Visit us
  • Submit a Medical Inquiry
  • Submit a Media Inquiry
  • —
  • Privacy Policy
  • Terms & Conditions
  • Accessibility
© 2023 Genentech, Inc. All rights reserved. This site is intended for US residents only.